HYPERBARIC OXYGEN THERAPY
Conditions
Hyperbaric Oxygen Therapy (HBOT) is FDA-approved for a defined set of medical conditions. When used for these on-label indications, treatment is often eligible for insurance coverage, making HBOT accessible to many patients.
HBOT is also widely utilized for off-label applications that are supported by peer-reviewed research and clinical experience worldwide. These uses are not FDA-approved indications and are typically not covered by insurance, nor are they commonly offered in hospital-based hyperbaric programs.
At Scottsdale Hyperbaric Center, we provide HBOT for both FDA-approved indications and select off-label applications when appropriate. All sessions are delivered with appropriate medical oversight and informed consent. For referral information, eligibility questions, or to discuss options, please contact our office at 480-590-5277.
UHMS-Recognized Clinical Indications
(FDA-Approved / On-Label)
These conditions are recognized by the Undersea & Hyperbaric Medical Society (UHMS) and approved by the FDA for the use of Hyperbaric Oxygen Therapy (HBOT). Many of these indications may be eligible for insurance coverage when established medical criteria are met.
Appropriate medical evaluation, supporting clinical documentation, and demonstration of medical necessity are required prior to treatment consideration.
Air or Gas Embolism
Carbon Monoxide Poisoning ± Cyanide Poisoning
Clostridial Myositis & Myonecrosis (Gas Gangrene)
Crush Injury, Compartment Syndrome & Acute Traumatic Ischemia’s
Decompression Sickness
Central Retinal Artery Occlusion
Selected Problem Wounds / Arterial Insufficiencies
Severe Anemia
Intracranial Abscess
Necrotizing Soft Tissue Infections
Refractory Osteomyelitis
Delayed Radiation Injury (Soft Tissue & Bone)
Compromised Grafts & Flaps
Acute Thermal Burns
Idiopathic Sudden Sensorineural Hearing Loss
Avascular Necrosis (Osteonecrosis)
Non-Covered Conditions
(Off-Label Use)
Some conditions are considered off-label for Hyperbaric Oxygen Therapy, meaning they are not FDA-approved indications. These treatments are typically not covered by insurance and are generally offered on a self-pay basis.
Appropriate medical evaluation and clinical screening are required to determine whether treatment may be appropriate.
Fibromyalgia
Multiple Sclerosis (MS)
Erectile Dysfunction
Crohn’s Disease
Sports Injury
Stroke
Post traumatic stress disorder (PTSD)
Concussion
Lyme Disease
Traumatic Brain Injury
Recovery from Plastic Surgery
Post-COVID-19 condition (Long COVID)
Migraine
Irritable Bowel Syndrome
Others not listed